Japan Alteplase Clinical Trial (J-ACT): Efficacy and Safety Study of Tissue Plasminogen Activator (Alteplase) for Ischemic Stroke

Clinical trial NCT00147316 · COMPLETED

Trial details

NCT number: NCT00147316
Sponsor: Tanabe Pharma Corporation
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Cerebral Infarction Brain Ischemia

Start date: 2002-04-01
Enrollment: 103

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.